Intervention not reported
Insulin ‐ hypoglycaemia (< 60 mg/dL) · patients with leading to fewer clinical adverse events
The intervention showed no clear difference in insulin ‐ hypoglycaemia (< 60 mg/dL) (low certainty).
1 finding from 1 review
Intervention not reported
Insulin ‐ severe hypoglycaemia (< 40 mg/dL) · patients with leading to fewer clinical adverse events
It is very uncertain whether the intervention changes insulin ‐ severe hypoglycaemia (< 40 mg/dL) (very low certainty).
1 finding from 1 review
Intervention not reported
Aminoglycoside antibiotics ‐ nephrotoxicity · patients with leading to fewer clinical adverse events
The intervention showed no clear difference in aminoglycoside antibiotics ‐ nephrotoxicity (low certainty).
1 finding from 1 review
Intervention not reported
Length of stay (days) · saving healthcare resources
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ oral anticoagulants · saving healthcare resources
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ insulin · saving healthcare resources
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ theophylline · saving healthcare resources
1 finding from 1 review
Intervention not reported
Serum concentrations ‐ theophylline · patients with leading serum concentrations within therapeutic range
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ aminoglycoside antibiotics · saving healthcare resources
1 finding from 1 review
Intervention not reported
Length of stay (days) ‐ anti‐rejection drugs · saving healthcare resources
1 finding from 1 review
Intervention not reported
Proportion of participants within therapeutic range ‐ aminoglycoside antibiotics: % of participants with peak concentrations adequate after 2 days · patients with leading serum concentrations within therapeutic range
The intervention probably leads to higher proportion of participants within therapeutic range ‐ aminoglycoside… (moderate certainty).
1 finding from 1 review
Intervention not reported
Proportion of participants with toxic drug levels ‐ theophylline · patients with leading serum concentrations within therapeutic range
The intervention showed no clear difference in proportion of participants with toxic drug levels ‐ theophylline (moderate certainty).
1 finding from 1 review
Intervention not reported
Oral anticoagulants: time in target INR range (%) · patients with leading physiological parameters within therapeutic range
1 finding from 1 review
Intervention not reported
Insulin: time in target glucose range (%) · patients with leading physiological parameters within therapeutic range
1 finding from 1 review
Intervention not reported
Time to achieve therapeutic range ‐ oral anticoagulants: time to achieve therapeutic prothrombin ratio (days) · patients with reducing time to achieve therapeutic control
1 finding from 1 review
Intervention not reported
Time to achieve therapeutic range ‐ insulin: time to achieve therapeutic control (hours) · patients with reducing time to achieve therapeutic control
1 finding from 1 review
Intervention not reported
Time to stabilization ‐ oral anticoagulants: time to stabilization (days) · patients with reducing time to achieve therapeutic control
1 finding from 1 review
Intervention not reported
Patient outcome · Health professionals
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Professional behavior (process of care outcomes) · Health professionals
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Knowledge · Health professionals
1 finding from 1 review